Course Name

PCPM - Ateneo CCE Diploma in Pharmaceutical Medicine & Management Batch 5

Schedule

May 02, 2020 - September 26, 2020

Saturdays

9:00 am - 6:00 pm

Regular Rate:

Php 90,000

PCPM - Ateneo CCE Diploma in Pharmaceutical Medicine & Management Batch 5

Description

Pharmaceutical Medicine is the medical scientific discipline concerned with the discovery, development, evaluation, registration, monitoring and medical aspects of the marketing of medicines for the benefit of patients and the health of the community.

In terms of governance, pharmaceutical physicians/ medical & regulatory personnel are accountable for the naturegality and standards, including ethical standards, of their work to their employers, to their professional bodies, and under the law as administered by the national Drug Regulatory Authority.

The Ateneo-PCPM Diploma in Pharmaceutical Medicine and Management consists of seven modules that aim to provide the technical knowledge and skills that will equip the pharmaceutical physicians/ medical and regulatory personnel with a core set of competencies aligned with international standards for the appreciation and/or practice of pharmaceutical medicine, at same time in line with Ateneo’s thrust on nation-building.

Who should attend

Medical doctors, allied health professionals, and management executives who want to gain competencies in the disciplines involving discovery, development, evaluation, monitoring and medical aspects in marketing of medicines for the benefit of patients and public 

After the course, you will develop the competencies of the International Federation of Associations of Pharmaceutical Physicians (IFAPP):

  1. Understand and apply medical science principles and statistics in the evaluation, development, and discovery of new medicines within the context of regulatory environments;
  2. Design, execute clinical trials and prepare manuscripts or reports for publication and regulatory submissions;
  3. Interpret effectively the regulatory requirements for the clinical development of a new drug, product life cycle, to ensure its appropriate therapeutic use and proper risk management;
  4. Evaluate the choice, application, and analysis of post-authorization surveillance methods to meet national/international agency requirements for proper information and risk minimization to patients and clinical trial subjects;
  5. Combine the principles of clinical research and business ethics for the conduct of clinical trials and commercial operations;
  6. Appraise the pharmaceutical business activities in the healthcare environment to ensure they remain appropriate, ethical, and legal to keep the welfare of patients and subjects in the promotion of medicines and design of clinical trials; and
  7. Able to apply the principles and practice of people management and leadership, effective communication, and interpersonal skills to influence key stakeholders and achieve scientific and business objectives. 
  • Discovery of Medicines and Early Development
    • Therapeutics in pharmacology
    • Discovery of new medicines
    • Planning and organization
    • Regulation and ethics
    • Pre-clinical drug development
    • Exploratory clinical development
    • Clinical Pharmacokinetics
  • Clinical Development and Clinical Trials
    • Clinical trial planning and management
    • Clinical trial designs, conduct, and documentation
    • Trial design, hypothesis testing, power
    • Measurement and types of data
    • Data collection and management
    • Types of analysis
    • Interpretation of study design, analysis and results
  • Medicine Regulation
    • Legal and medicines regulation
    • Good practices, harmonization, CTD, labels, AR reports, drug abuse-dependence
    • Clinical trials, ethics, drug classification
  • Drug Safety Surveillance
    • Drug safety regulation
    • Drug safety in preclinical phase 
    • Drug safety in clinical trials
    • Pharmacovigilance
    • Pharmacoepidemiology
  • Ethics and Subject Protection
  • Healthcare Marketplace
  • Communication and Management
    • Role of medical department

Dr. Cynthia I. Valencia, M.D.

is a clinical professor of the Department of Pharmacology and Toxicology, College of Medicine in the University of the Philippines – Manila. 


Prior to this, she held distinctive roles, such as: Head of the Research Grants Administration Office in the University of the Philippines – Manila; President of the Philippine Society of Experimental and Clinical Pharmacology; Editor-in-Chief of Acta Medica Philippina, the official journal of the University of the Philippines – College of Medicine and Public Health and the Philippine General Hospital; Consultant of the National Drug Information Center (NDIC), a project of the World Health Organization (WHO) at the University of the Philippines – College of Medicine. 


She was also a recipient of the World Health Organization (WHO) Headquarters Research Fellowship Grant in Clinical Pharmacology at the Case Western Reserve University School of Medicine, in Cleveland, Ohio and a national awardee of the Achievement Award in Medicine in National Research Council of the Philippines (NRCP).

 

Dr. Herbert Ho, M.D.

is an Associate Professor at the Department of Pharmacology and Taxicology, University of the Philippines Manila. Concurrently, he is a Consultant in Internal Medicine and Endocrinology at Manila Doctors Hospital. He is also the Treasurer of Philippine College of Pharmaceutical Medicine.

He is a fellow of the Philippine College of Physicians, Philippine Society of Endocrinology and Metabolism, Philippine Society of Experimental and Clinical Pharmacology, and International Member of The Endocrine Society, USA.  
 
He also contributed in publications, such as: Cardiovascular Drugs, Diuretics, The Association between the CYP3A5 Genotype and Blood Pressure, and Effects of CYP2D6 Genotype and Antidepressants on Tamoxifen Metabolism during Adjuvant Breast Cancer Treatment, to name a few.    

Dr. Ho earned his Doctor of Medicine degree from the University of the Philippines Manila. He also completed his Non Degree Courses in NIH Course on Principles of Clinical Pharmacology, Clinical Pharmacokinetics, Pharmacogenetics and Physiological Disposition of Drugs, Certification Program for the Protection of Human Subjects in Research, and Introduction to Research Ethics from Indiana University School of Medicine.  

 

Ronald R. Matias, PhD

is the Director of the Biological Science Department in the United Laboratories Incorporated (UNILAB).  


Prior to this, he held distinctive roles, such as: Co-director for Basic Research and Biotechnology in St. Luke’s Medical Center; Scientist and Manager for Biological Science Department in UNILAB; and Assistant Professor of St. Luke’s College of Medicine and University of the Philippines – Diliman.  


Dr. Matias also contributed in scientific publications, such as: The Hybrid Vibrio cholera El Tor Lacking SXT Identified as the Cause of a cholera Outbreak in the Philippines;  Complete genome sequence of chikungunya virus isolated in the Philippines;  Genome sequencing of Vibrio cholera isolates from an outbreak in the Philippines; Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections; and Shotgun genome sequence of a Yersinia entercolitica isolate from the Philippines to name a few.  


He is also a recipient of various awards, such as: the Outstanding Health Research Award from the Philippine Council for Health Research and Development – Department of Science and Technology; the Don Pio Pedrosa Professorial Chair from the College of Science in the University of the Philippines – Diliman; and the Outstanding Young Scientist Award from the National Academy of Science and Technology among others. 


Dr. Matias obtained his Bachelors degree in Zoology, Masteral degree in Biology, and Doctorate degree in Zoology from the University of the Philippines – Diliman. He also obtained a Certificate in Advance Tropical Medicine from the Institute for Tropical Medicine in Nagasaki University – Japan, Dissertation research from Bernhard-Nocht Institute for Tropical Medicine, Hamburg, Germany, and Post – doctoral study  from the Gesselschaft fur Biotechnologische Forshung, Braunschweig, Germany. 

 

Jocelyn S. Bautista-Palacpac

is the Assistant Director at Institute of Herbal Medicine and a Faculty Member at the University of the Philippines Manila. She has extensive experience in Pharmaceutical Manufacturing, Quality Assurance, Product Formulation, Biopharmaceutics, Pharmacokinetics, and Herbal Medicine.   
 

Previously, she was the Dean of the College of Pharmacy, Chair of the Department of Industrial Pharmacy, and Chair of Department of Industrial Pharmacy at the University of the Philippines Manila.  

She has received numerous awards such as the Delfin and Marcela Samson Professorial Chair, Faculty Grant, Outstanding Alumni Award, Demetria Sumulong-Cojuangco Professorial Chair, Gawad Sentenaryo Professorial Chair, and Gruppo Medica Award for Outstanding Research in Herbal Medicine, among others.   
 

She is the author/co-author of publications mainly on medicinal plants and pharmacology such as: Guidebook on the Proper Use of Medicinal Plants;  Sambong as Antihyperurecemic; Perceptions on the Risk and Management of Unused Pharmaceuticals toward the Creation of Guidelines on Handling; and Disposal under the Asian Journal of Pharmaceutical Sciences, to name a few. 
 

Ms. Palacpac obtained her Bachelor’s and Master’s degree in Industrial Pharmacy from the University of the Philippines Manila. She also finished a Diploma Course on Research and Development of Products to Meet Public Health Needs from Nagasaki University, Sakamoto, Nagasaki, Japan. 

 

Mark Anthony Javelosa, M.S.

served as a Senior Biostatistician at the PPD, Inc. He was a lead statistician across challenging projects, size calculations and protocols, study design, and statistical analysis.  
 

He held other posts such as Consultant at Johnson & Johnson Consumer Group of Companies where he created work instructions for the data management and signal detection analysis of safety surveillance data of monograph drug, medical device and cosmetic products, Statistical Adviser to medical residents in research designs, protocol-writing, and analysis at Manila Doctors Hospital, and Assistant Professor of Elementary Statistics at University of the Philippines, among others.  
 

He is the author/co-author of the following publications: Epidemiological Risk Cancers of the Lung, Breast, Colon-Rectum and Oral Cavity: A case-control study in the Philippines; Measuring Satisfaction with Nursing Care of Patients Admitted in the Medical Wards of the Philippine General Hospital; and ASEAN and Trafficking in Persons: Using Data as a Tool to Combat Trafficking in Persons, to name a few.  
 

He is a member of the Philippine Statistical Association and International Network of Clinical Epidemiology.  
 

Mr. Javelosa obtained his Bachelor’s and Master’s degree in Statistics from the University of the Philippines.  

 

Suzette H. Lazo, M.D.

was the Director of the Food and Drug Administration (FDA). At present, she continues to serve the FDA and the Department of Health (DOH) as a resource person on technical issues and had been a regular lecturer of the FDA Academy. Also, she is a regular lecturer on Vaccine Pharmacovigilance for courses on Vaccinology conducted by the Philippine Foundation for Vaccination. 
 

Before joining FDA, Dr. Lazo worked with United Laboratories as medical researcher and eventually headed its Clinical Research Department. She served as a shot-term consultant with the World Health Organization and also joined the Department of Pharmacology and Toxicology of the University of the Philippines – College of Medicine as a Professorial Lecturer. She was the President of The Philippine Society of Experimental and Clinical Pharmacology and also served as Technical Adviser for Medicines Transparency Alliance and is a member of the International Society of Pharmacovigilance.  
 

Her work also included campaigns and research on counterfeit medicines in the Philippines, as well as monitoring and information drives to address unsafe toys and cosmetics. She pushed for the strengthening of pharmacovigilance in the country through legislation that formally established a pharmacovigilance framework for the Philippines. She supported the ongoing program for FDA certification under the Pharmaceutical Inspection Cooperation Scheme (PICs), reinforced FDA efforts to implement mandatory GMP for all manufacturing facilities in the country, as well as pushing for the inspection of foreign drug sources, expansion of the bioequivalence requirement, and strengthening of household/urban pesticide regulation. 
 

During her term, FDA was also engaged in a campaign with nutrition experts and the Philippine College of Physician to curve non-communicable diseases (NCD) through nutrition labelling. She reorganized the system of review of clinical trials in collaboration with World Health Organization (WHO), Department of Science and Technology –Philippine Council for Health Research and Development, Philippine Health Research Ethics Board (PHREB), academe and industry and the new regulatory system also included mandatory registration of all clinical trials in a national registry. She served as head of delegation to Geneva and helped defend articles for inclusion in the treaty which are intended to protect the public health against the deleterious effects of smoking tobacco. Before her term ended she initiated a full review of the FDA by the WHO. 
 

Dr. Lazo was awarded the Outstanding Alumna Award  for Leadership from her alma mater, the University of the East Ramon Magsaysay Memorial Medical Center (UERMMMC) and the Presidential Award from the Philippine College of Physicians for her efforts to promoting healthier food choices. 

 

John Q. Wong, M.D., MSC

has extensive experience in epidemiology and biostatistics, education and training, health financing, community health, occupational health, program management and evaluation, and pharmaceutical system management. Presently, he is a Faculty of the Ateneo School of Medicine and Public Health, the Ateneo Graduate School of Business, and the Ateneo School of Science and Engineering – Health Science Program. Concurrently, he is the Managing Director of Project Laan, Inc., a youth-led, school-based social enterprise that aims to generate resources for health for poor communities.  
 

He received the 2016 Roux Prize Awardee given by the Institute for Health Metrics and Evaluation of the University of Washington, for research on the Top 48 diseases comprising 80% of the burden of disease in the Philippines, aiding the formulation of the Philippine Health Insurance Company’s Guaranteed Health Benefits Package.  
 

Dr. Wong obtained his Bachelors degree in Biology, Doctor of Medicine, and Master of Science in Epidemiology from the University of Philippines-Manila.  

 

Guia Crisostomo-Tan, M.D.

is a practicing clinician and bioethicist.  She currently sits in various ethics committees including that of the UP-PGH, The Medical City (TMC) Hospital, De Los Santos-STI Mega Clinic, and the TMC Department of Otolaryngology-Head and Neck Surgery Ethics Committee, the latter two of which she chairs.  She is part of the Ethics Review Board of both the TMC and the Ateneo School of Medicine and Public Health (ASMPH).   
 

She used to be a member of the National Transplant Ethics Committee of the Department of Health and the Ethics Committee of the Pharmaceutical and Healthcare Association of the Philippines.  She is currently an associate professor and the Ethics subject expert of the ASMPH. 
 

She obtained her Medical degree from the University of the Philippines (UP) and then specialized in Otorhinolaryngology-Head and Neck Surgery at the UP-Philippine General Hospital (UP-PGH), with a subsequent observership in Neuro-otology from Sir Charles Gairdner Hospital in Perth, Western Australia. Later, she took her Masters degree in Bioethics also from the University of the Philippines. 

 

Dr. Sonia E. Bongala

is the Director of Medical Education & Research Division and an active Consultant of Makati Medical Center.  


Prior to this, she held other posts, such as: Chairman of the Department of Obstetrics and Gynecology, Department Manager of Accreditation and Unit – Total Services Division, Vice Chair of Institutional Review Board in Makati Medical Center, among others.  


She is also a fellow of the following professional memberships: Philippine Obstetrical and Gynecological Society, International College of Surgeons, Philippine College of Pharmaceutical Medicine, Philippine Society of Experimental and Clinical Pharmacology, to name a few. 


Dr. Bongala finished her Bachelor’s and Doctor of Medicine degree from University of Santo Tomas.

 

Dr. Marcial Balgos, PhD

is currently the Chair of the Leadership & Human Resource Department of the Ateneo Graduate School of Business, where he also teaches, in addition to teaching stints in the Ateneo School of Medicine and Public Health and the School of Social Sciences. He has done consulting projects for multinational and local companies, as well as government corporations and line agencies.

 

Previously, he headed up five business organizations as General Manager and President; he also worked in managerial functions in HR, OD, public relations, strategic planning, and training -- a business career that spanned more than 25 years.  
 

Dr. Balgos earned a Bachelor’s degree in Legal Management, Master’s degree in Business Administration, and Doctorate degree in Leadership Studies from the Ateneo de Manila University.  

 

Dr. Madeleine Valera

is  the Executive Director of infant and pediatric Association of the Philippines, Faculty of Ateneo School of Business and serves as Consultant and Adviser to World Bank, USAID, WHO-WPRO, ADB, Department of Health, Philippine Health Insurance Corporation, Private Hospital Association of the Philippines, Hospital Management Asia, Zuellig Family Foundation and National Privacy Commission.


She was a former Senior Vice President of PHilhealth who initiated the use of Health Technology Assessment in the Philippine National Health Insurance in 1999 as a tool to ensure appropriate use of technologies in the social insurance benefit and in the promotion of quality assurance. Dr. Valera also introduced  provider payment mechanism to PHIC such as Diagnosis Related Grouping (DRG), global budget for OFW outpatient benefits. As an advocate of Quality in healthcare, Dr. Valera supervised the development of the PHIC QA Benchbook for institutional providers accreditation.

As a former Undersecretary of Health, Dr. Valera, institutionalized HTA and Drug Price Reference Index in the Department of Health for drugs and medicines procurement and inclusion of drugs in the National Drug Formulary.

She has over 20 years experience in Health Policy Development, Pharmaceutical Management, Health Systems Strengthening, Public Health Administration, Public-Private Partnership and International and Regional Coordination, Disaster Prevention/ Preparedness and Public Health Financing, Primary Health Care and Quality Assurance. She was also involved in the drafting of several Health laws and policies and their Implementing Rules and Regulations such as the Generics Law, National Health Insurance Law, RPRH Law, Magna Carta of Health Workers, SIN Tax Law.

 

Dr. Dennis Ryan V. Cruz


(Director, Student Affairs and Formation Leadership, Ethics and Human Resources Department)
 
He is a seasoned executive that specializes in Investment Banking, Consumer Real Estate Banking and Strategic Management. He graduated with a degree in Bachelor of Science in Business Management and completed his Executive MBA degree from the Ateneo Graduate School of Business Joint Program with Regis University, Colorado, USA. From 2002 to 2006, he delved in Graduate Philosophical, Education and Media studies from the Ateneo de Manila.

Register Now